Connors Investor Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,238
| Closed | -$208K | – | 165 |
|
|
2023
Q4 | $208K | Sell |
7,238
-705
| -9% | -$21.3K | 0.02% | 140 |
|
|
2023
Q3 | $263K | Sell |
7,943
-1,050
| -12% | -$37.1K | 0.03% | 122 |
|
|
2023
Q2 | $330K | Sell |
8,993
-12,471
| -58% | -$485K | 0.04% | 120 |
|
|
2023
Q1 | $876K | Sell |
21,464
-209
| -1% | -$9.03K | 0.1% | 103 |
|
|
2022
Q4 | $1.11M | Hold |
21,673
| – | – | 0.14% | 97 |
|
|
2022
Q3 | $948K | Sell |
21,673
-415
| -2% | -$20.2K | 0.12% | 97 |
|
|
2022
Q2 | $1.16M | Sell |
22,088
-760
| -3% | -$38.7K | 0.15% | 95 |
|
|
2022
Q1 | $1.18M | Sell |
22,848
-495
| -2% | -$25.7K | 0.12% | 99 |
|
|
2021
Q4 | $1.38M | Sell |
23,343
-460
| -2% | -$22.8K | 0.14% | 100 |
|
|
2021
Q3 | $1.02M | Sell |
23,803
-785
| -3% | -$34.8K | 0.11% | 105 |
|
|
2021
Q2 | $963K | Sell |
24,588
-1,950
| -7% | -$75.8K | 0.1% | 104 |
|
|
2021
Q1 | $961K | Sell |
26,538
-244,601
| -90% | -$8.68M | 0.11% | 105 |
|
|
2020
Q4 | $9.98M | Sell |
271,139
-28,800
| -10% | -$1.06M | 1.24% | 33 |
|
|
2020
Q3 | $10.4M | Sell |
299,939
-7,318
| -2% | -$257K | 1.46% | 24 |
|
|
2020
Q2 | $9.53M | Sell |
307,257
-17,439
| -5% | -$592K | 1.41% | 27 |
|
|
2020
Q1 | $10.1M | Sell |
324,696
-535
| -0.2% | -$18.2K | 1.74% | 21 |
|
|
2019
Q4 | $12.1M | Buy |
325,231
+1,782
| +0.6% | +$63.5K | 1.54% | 27 |
|
|
2019
Q3 | $11M | Sell |
323,449
-6,288
| -2% | -$229K | 1.51% | 31 |
|
|
2019
Q2 | $13.6M | Buy |
329,737
+43,301
| +15% | +$1.72M | 1.8% | 17 |
|
|
2019
Q1 | $11.5M | Buy |
286,436
+28,305
| +11% | +$1.13M | 1.57% | 22 |
|
|
2018
Q4 | $10.7M | Sell |
258,131
-8,679
| -3% | -$360K | 1.67% | 21 |
|
|
2018
Q3 | $11.2M | Buy |
266,810
+8,026
| +3% | +$309K | 1.5% | 25 |
|
|
2018
Q2 | $8.91M | Buy |
258,784
+81
| +0% | +$2.77K | 1.25% | 30 |
|
|
2018
Q1 | $8.71M | Buy |
258,703
+1,096
| +0.4% | +$37.7K | 1.28% | 28 |
|
|
2017
Q4 | $8.85M | Buy |
257,607
+4,863
| +2% | +$166K | 1.27% | 27 |
|
|
2017
Q3 | $8.56M | Buy |
252,744
+4,552
| +2% | +$146K | 1.29% | 28 |
|
|
2017
Q2 | $7.91M | Buy |
248,192
+8,369
| +3% | +$264K | 1.24% | 32 |
|
|
2017
Q1 | $7.77M | Buy |
239,823
+27
| +0% | +$851 | 1.28% | 32 |
|
|
2016
Q4 | $7.39M | Buy |
239,796
+288
| +0.1% | +$8.79K | 1.26% | 31 |
|
|
2016
Q3 | $7.7M | Buy |
239,508
+10,152
| +4% | +$339K | 1.35% | 29 |
|
|
2016
Q2 | $7.66M | Sell |
229,356
-842
| -0.4% | -$26.9K | 1.49% | 21 |
|
|
2016
Q1 | $6.47M | Buy |
230,198
+5,286
| +2% | +$151K | 1.29% | 31 |
|
|
2015
Q4 | $6.89M | Buy |
224,912
+16,574
| +8% | +$521K | 1.4% | 23 |
|
|
2015
Q3 | $6.21M | Buy |
208,338
+4,037
| +2% | +$129K | 1.4% | 21 |
|
|
2015
Q2 | $6.49M | Buy |
204,301
+11,053
| +6% | +$360K | 1.34% | 24 |
|
|
2015
Q1 | $6.38M | Buy |
193,248
+8,611
| +5% | +$274K | 1.38% | 19 |
|
|
2014
Q4 | $5.46M | Buy |
184,637
+5,397
| +3% | +$155K | 1.24% | 26 |
|
|
2014
Q3 | $5.03M | Buy |
179,240
+2,667
| +2% | +$74.9K | 1.22% | 28 |
|
|
2014
Q2 | $4.97M | Buy |
176,573
+3,383
| +2% | +$96.4K | 1.19% | 25 |
|
|
2014
Q1 | $5.28M | Buy |
173,190
+7,504
| +5% | +$224K | 1.28% | 17 |
|
|
2013
Q4 | $4.82M | Buy |
165,686
+14,820
| +10% | +$431K | 1.2% | 25 |
|
|
2013
Q3 | $4.11M | Buy |
150,866
+23,678
| +19% | +$644K | 1.16% | 26 |
|
|
2013
Q2 | $3.38M | Buy |
+127,188
| New | +$3.51M | 1.09% | 29 |
|
Other funds holding PFE
Connors Investor Services's PFE Position: Q1 2024 in Review
Connors Investor Services sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,238 shares — an estimated $208K sold.
Connors Investor Services first reported a position in PFE in Q2 2013 and held it in 43 quarters. The position peaked at $13.6M in Q2 2019. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Connors Investor Services reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Connors Investor Services sold 7,238 Pfizer shares in Q1 2024, an estimated $208K.
- Connors Investor Services first reported a position in Pfizer in Q2 2013 and held it in 43 quarters.
- Connors Investor Services's Pfizer position peaked at $13.6M in Q2 2019.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Connors Investor Services's 13F filing for Q1 2024, filed 10 May 2024.